5 results
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Ventilator-Associated Pneumonia ... Staphylococcus aureus Coverage ... /Gram-Negative Coverage ... Are Appropriate #Management ... #Antibiotics #VAP
An evidence-based algorithm to guide the use of MRSA coverage (in community acquired pneumonia) is shown
evidence-based algorithm ... (in community acquired ... pneumonia) is shown ... #Algorithm #CAP ... #Management #Deescalate
Antibiotics for severe community-onset pneumonia 

Atypical coverage always 

- Usually azithromycin 500 mg daily 

- Doxycycline
severe community-onset ... pneumonia Atypical ... #Acquired #Pneumonia ... #CAP #Antibiotics ... #Coverage #Management
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Pneumonia (CAP) ... #Community #Acquired ... #Pneumonia #Antibiotics ... Treatment #Regimen #Management ... #Guidelines #pharmacology
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Community Acquired ... Pneumonia (CAP) ... Diagnosis and Management ... RESPIRATORY 96.1% • Empiric ... antibiotic therapy